Source: Medicines & Healthcare Products Regulatory Agency (GB) | Revision Year: 2018 | Publisher: Milpharm Limited, Ares, Odyssey Business Park, West End Road, South Ruislip HA4 6QD, United Kingdom
Carvedilol 12.5 mg film-coated tablets.
Film-coated tablets white to off-white, oval, engraved with “F58” on one side and scored on the other side. The tablet can be divided into equal doses.
Each tablet contains 12.5 mg of carvedilol.
Excipient(s) with known effect: Each tablet contains 114.5 mg of lactose monohydrate and 2.5 mg of sucrose.
For a full list of excipients, see section 6.1.
Carvedilol is a vasodilatory non-selective beta-blocker, which reduces the peripheral vascular resistance by selective alpha1-receptor blockade and suppresses the renin-angiotensin system through non-selective beta-blockade. Plasma renin activity is reduced and fluid retention is rare.
Silica colloidal anhydrous
Crospovidone (Type A)
Crospovidone (Type B)
Titanium dioxide (E171)
PVC/PE/PVDC – Aluminum:
Package sizes: 5, 7, 10, 14, 15, 20, 28, 30, 40, 50, 56, 60, 90, 98, 100, 120, 150, 200, 250, 300, 400, 500 and 1000 film-coated tablets.
Bottle of high density polyethylene (HDPE) with a white cap, opaque polypropylene.
Package sizes: 30, 50, 60, 100, 250, 500 and 1000 film-coated tablets.
Not all pack sizes may be marketed.
Milpharm Limited, Ares, Odyssey Business Park, West End Road, South Ruislip HA4 6QD, United Kingdom
Date of first authorisation: 04/10/2012
Date of last renewal: 03/02/2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.